Could a simple supplement boost knee injection results for arthritis sufferers?

NCT ID NCT07680101

First seen Jul 02, 2026 ยท Last updated Jul 02, 2026

Summary

This study tests whether adding an oral supplement (PEA) to a series of knee injections (adelmidrol and hyaluronic acid) can better reduce pain and improve function in people with knee arthritis. The injections aim to protect the joint from damage, while the supplement may help calm nerve-related inflammation. The trial involves 80 adults with knee osteoarthritis or rheumatoid arthritis who will receive either the injections alone or the injections plus the oral supplement.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Adelmidrol 2% / Hyaluronic Acid 1% (injection) and micronized/ultramicronized Palmitoylethanolamide (oral supplement)
What this could lead to
If successful, this combination could offer a new way to ease knee pain and improve mobility for people with osteoarthritis or rheumatoid arthritis.
What could go wrong
This is a small, early-stage study with only 80 participants, so results may not apply to everyone. The supplement may not provide added benefit over the injection alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE JOINT DISEASE OF KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Azienda Ospedaliera Universitaria Integrata Verona

    Verona, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.